Items Tagged ‘ovarian suppression’

December 19th, 2014

Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer

By

Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results of the Suppression of Ovarian Function Trial (SOFT) presented at the 2014 San Antonio Breast Cancer Symposium in Texas.[1] These results were also published online simultaneously in The New […]

View full entry

Tags: aromasin, Breast Cancer, News, ovarian suppression, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer, tamoxifen